Skip to main content
FDA-Approved GLP-1 Medications

Lose 15-22% of Your Body Weight

Clinically proven medications that work with your body's natural hunger signals. Most patients see results within the first month.

Reduces appetite
Feel full longer
Heart health benefits
Check If You Qualify 2-minute assessment · No commitment
20% Average weight loss with Tirzepatide*
*Clinical trial results over 72 weeks

See Your Potential Results

Based on clinical trial data for GLP-1 medications

250 lbs
With Semaglutide (15-17%) 37-42 lbs
Calculate your exact BMI

How GLP-1 Medications Work

These medications mimic hormones your body naturally produces after eating.

1

Reduces Hunger Signals

GLP-1 acts on appetite centers in your brain, naturally reducing cravings and the urge to overeat.

2

Slows Digestion

Food stays in your stomach longer, helping you feel satisfied after smaller portions.

3

Regulates Blood Sugar

Improves how your body responds to insulin, helping stabilize energy levels throughout the day.

What makes Tirzepatide different?

Tirzepatide (Mounjaro®, Zepbound®) activates both GIP and GLP-1 receptors, providing enhanced results compared to GLP-1-only medications. Clinical trials show 5-7% more weight loss on average.

Compare All Options

Mounjaro Tirzepatide Zepbound Tirzepatide Wegovy Semaglutide Ozempic Semaglutide
Mechanism Dual GIP/GLP-1 Dual GIP/GLP-1 GLP-1 GLP-1
Avg. Weight Loss 20-22% 20-22% 15-17% 14-15%
FDA Approved For Diabetes* Weight Loss Weight Loss Diabetes*
Our Price $275/mo $275/mo $175/mo $175/mo
You Save 75% 74% 87% 82%

*Ozempic and Mounjaro are FDA-approved for diabetes and prescribed off-label for weight loss.

500+ Patients Treated
4.9★ Patient Rating
Board-Certified Physician/span>
Indiana In-Person & Telehealth

Common Questions

During your consultation, our providers evaluate your health history, BMI, goals, and any existing conditions to recommend the best medication. Both medication types are highly effective—the choice often depends on your response to treatment and budget.

Yes. Semaglutide and Tirzepatide are FDA-approved with extensive clinical trial data. They have been studied in thousands of patients. Our medical team monitors you throughout treatment.

Most patients notice reduced appetite within 1-2 weeks. Visible weight loss typically begins by weeks 4-8. Maximum results develop over 12-18 months as your dose is optimized.

We work directly with compounding pharmacies that produce FDA-regulated versions of these medications at a fraction of brand-name costs. Same active ingredients, same results, without the retail markup.

Ready to Start Your Weight Loss Journey?

Take our 2-minute quiz to see if you qualify for GLP-1 medication therapy.